123 related articles for article (PubMed ID: 38519447)
1. Gastrointestinal release site for delayed release and gelatin capsules in healthy dogs.
Stone CB; Rudinsky AJ; Urion RJ; March SB; Winston JA
J Vet Pharmacol Ther; 2024 Mar; ():. PubMed ID: 38519447
[TBL] [Abstract][Full Text] [Related]
2. Bioequivalence studies of a new valproic acid delayed-release capsule and divalproex sodium delayed-release tablet.
Garikipati V; Toops DS; Fang Q
Curr Med Res Opin; 2008 Jul; 24(7):1869-76. PubMed ID: 18593524
[TBL] [Abstract][Full Text] [Related]
3. Comparison of protection and release behavior of different capsule polymer combinations based on L. acidophilus survivability and function and caffeine release.
Marzorati M; Calatayud M; Rotsaert C; Van Mele M; Duysburgh C; Durkee S; White T; Fowler K; Jannin V; Bellamine A
Int J Pharm; 2021 Sep; 607():120977. PubMed ID: 34384885
[TBL] [Abstract][Full Text] [Related]
4. Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.
Matsuda K; Takaya T; Shimoji F; Muraoka M; Yoshikawa Y; Takada K
J Drug Target; 1996; 4(2):59-67. PubMed ID: 8894965
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture.
Digenis GA; Sandefer EP; Page RC; Doll WJ; Gold TB; Darwazeh NB
Pharm Res; 2000 May; 17(5):572-82. PubMed ID: 10888309
[TBL] [Abstract][Full Text] [Related]
6. Combined Application of MRI and the Salivary Tracer Technique to Determine the in Vivo Disintegration Time of Immediate Release Formulation Administered to Healthy, Fasted Subjects.
Sager M; Grimm M; Jedamzik P; Merdivan S; Kromrey ML; Hasan M; Koziolek M; Tzvetkov MV; Weitschies W
Mol Pharm; 2019 Apr; 16(4):1782-1786. PubMed ID: 30821987
[TBL] [Abstract][Full Text] [Related]
7. Polymer-coated gelatin capsules as oral delivery devices and their gastrointestinal tract behaviour in humans.
Narayani R; Rao KP
J Biomater Sci Polym Ed; 1995; 7(1):39-48. PubMed ID: 7662616
[TBL] [Abstract][Full Text] [Related]
8. Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules.
Curatolo W; Liu P; Johnson BA; Hausberger A; Quan E; Vendola T; Vatsaraj N; Foulds G; Vincent J; Chandra R
Pharm Res; 2011 Jul; 28(7):1531-9. PubMed ID: 21331473
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of the biopharmaceutics characteristics of solid oral Modified-Release drug products in approved US FDA NDAs designated as Extended-Release or Delayed-Release formulations.
Ahmed N; Ly H; Pan A; Chiang B; Raines K; Janwatin T; Hamed S; Dave K
Eur J Pharm Biopharm; 2023 Dec; 193():294-305. PubMed ID: 37984592
[TBL] [Abstract][Full Text] [Related]
10. Intragastric behavior and absorption kinetics of a normal and "floating" modified-release capsule of isradipine under fasted and fed conditions.
Mazer N; Abisch E; Gfeller JC; Laplanche R; Bauerfeind P; Cucala M; Lukachich M; Blum A
J Pharm Sci; 1988 Aug; 77(8):647-57. PubMed ID: 2974884
[TBL] [Abstract][Full Text] [Related]
11. A developed composite hard-gelatin capsules: delayed-release enteric properties.
Nezhad Mohseni M; Najafpour Darzi G; Ramezani R; Jahani A
Heliyon; 2022 Dec; 8(12):e12265. PubMed ID: 36619422
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Capsule-in-Capsule Combinations on In Vivo Disintegration in Human Volunteers: A Combined Imaging and Salivary Tracer Study.
Rump A; Weiss FN; Schulz L; Kromrey ML; Scheuch E; Tzvetkov MV; White T; Durkee S; Judge KW; Jannin V; Bellamine A; Weitschies W; Grimm M
Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959284
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of the gastrointestinal delivery of acid-sensitive pancrelipase in a next generation enteric capsule using an exocrine pancreatic insufficiency disease model.
Jannin V; Duysburgh C; Gonzalez V; Govaert M; Agisson M; Marzorati M; Madit N
Int J Pharm; 2023 Jan; 630():122441. PubMed ID: 36442722
[TBL] [Abstract][Full Text] [Related]
14. In vivo characterization of enTRinsic™ drug delivery technology capsule after intake in fed state: A cross-validation approach using salivary tracer technique in comparison to MRI.
Sager M; Grimm M; Aude P; Schick P; Merdivan S; Hasan M; Kromrey ML; Sivert A; Benameur H; Koziolek M; Tzvetkov MV; Weitschies W
J Control Release; 2019 Nov; 313():24-32. PubMed ID: 31626859
[TBL] [Abstract][Full Text] [Related]
15. Prolonged-release hard gelatin capsules of furosemide for the treatment of dogs.
Smal J; Haapala O; Marvola M; Kuusela S; Happonen I
J Vet Pharmacol Ther; 1995 Feb; 18(1):17-23. PubMed ID: 7752301
[TBL] [Abstract][Full Text] [Related]
16. Analysis of nifedipine absorption from soft gelatin capsules using PBPK modeling and biorelevant dissolution testing.
Thelen K; Jantratid E; Dressman JB; Lippert J; Willmann S
J Pharm Sci; 2010 Jun; 99(6):2899-904. PubMed ID: 20014280
[TBL] [Abstract][Full Text] [Related]
17. Gelatin and Non-Gelatin Capsule Dosage Forms.
Gullapalli RP; Mazzitelli CL
J Pharm Sci; 2017 Jun; 106(6):1453-1465. PubMed ID: 28209365
[TBL] [Abstract][Full Text] [Related]
18. Effect of Gongronema latifolium on gastric emptying in healthy dogs.
Ogbu SO; Agwu KK; Asuzu IU
World J Gastroenterol; 2013 Feb; 19(6):897-902. PubMed ID: 23431049
[TBL] [Abstract][Full Text] [Related]
19. Development of a colonic release capsule dosage form and the absorption of insulin.
Kraeling ME; Ritschel WA
Methods Find Exp Clin Pharmacol; 1992 Apr; 14(3):199-209. PubMed ID: 1378164
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting zero-order release kinetics of porous gelatin capsules.
Chen GL; Hao WH
Drug Dev Ind Pharm; 1998 Jun; 24(6):557-62. PubMed ID: 9876623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
